These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15523080)

  • 1. Canadian province seeks control of its genes.
    Longtin R
    J Natl Cancer Inst; 2004 Nov; 96(21):1567-9. PubMed ID: 15523080
    [No Abstract]   [Full Text] [Related]  

  • 2. Canadian Research Ethics Board Leadership Attitudes to the Return of Genetic Research Results to Individuals and Their Families.
    Fernandez CV; O'Rourke PP; Beskow LM
    J Law Med Ethics; 2015; 43(3):514-22. PubMed ID: 26479560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research governance, bio-politics and political will: recent lessons from Newfoundland and Labrador.
    Pullman D
    Health Law Rev; 2005; 13(2-3):75-9. PubMed ID: 16459418
    [No Abstract]   [Full Text] [Related]  

  • 4. Duty to warn and genetic disease.
    Hodgkinson K; Pullman D
    Can J Cardiovasc Nurs; 2010; 20(1):12-5. PubMed ID: 20301857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biobanking primer: down to basics.
    Auray-Blais C; Patenaude J
    Science; 2007 May; 316(5826):830. PubMed ID: 17495155
    [No Abstract]   [Full Text] [Related]  

  • 6. Research ethics boards: error and misconception.
    Bowen A
    PLoS Med; 2006 Oct; 3(10):e458; author reply e460, e471. PubMed ID: 17076571
    [No Abstract]   [Full Text] [Related]  

  • 7. Regional ethics organizations for protection of human research participants.
    Wood A; Grady C; Emanuel EJ
    Nat Med; 2004 Dec; 10(12):1283-8. PubMed ID: 15580245
    [No Abstract]   [Full Text] [Related]  

  • 8. Research ethics boards: the protection of human subjects.
    Lestou VS; Ondrusek N; Blajchman MA
    PLoS Med; 2006 Oct; 3(10):e472; author reply e471. PubMed ID: 17076582
    [No Abstract]   [Full Text] [Related]  

  • 9. Ethical issues in medical-sequencing research: implications of genotype-phenotype studies for individuals and populations.
    Foster MW; Sharp RR
    Hum Mol Genet; 2006 Apr; 15 Spec No 1():R45-9. PubMed ID: 16651368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining the level of statistician participation on Canadian-based research ethics boards.
    Thabane L; Childs A; Lafontaine A
    IRB; 2005; 27(2):11-4. PubMed ID: 15948326
    [No Abstract]   [Full Text] [Related]  

  • 11. Food and Drug Administration public hearing on the conduct of emergency clinical research: testimony of Dr. Weisfeldt.
    Weisfeldt ML
    Acad Emerg Med; 2007 Apr; 14(4):e69. PubMed ID: 17331914
    [No Abstract]   [Full Text] [Related]  

  • 12. Canadian research ethics boards, MRI research risks, and MRI risk classification.
    Marshall J; Hadskis MR
    IRB; 2009; 31(4):9-15. PubMed ID: 19697539
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetics. No longer de-identified.
    McGuire AL; Gibbs RA
    Science; 2006 Apr; 312(5772):370-1. PubMed ID: 16627725
    [No Abstract]   [Full Text] [Related]  

  • 14. Research ethics boards: size, not money.
    Hill J
    PLoS Med; 2006 Oct; 3(10):e457; author reply e460, e471. PubMed ID: 17076570
    [No Abstract]   [Full Text] [Related]  

  • 15. Research involving children: regulations, review boards and reform.
    Gandhi R
    J Health Care Law Policy; 2005; 8(2):264-330. PubMed ID: 16471026
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of the ethical review process in Sudan.
    Elsayed DE; Kass NE
    Dev World Bioeth; 2007 Dec; 7(3):143-8. PubMed ID: 18021119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tyranny of 'genethics'.
    Turner L
    Nat Biotechnol; 2003 Nov; 21(11):1282. PubMed ID: 14595353
    [No Abstract]   [Full Text] [Related]  

  • 18. Benefit sharing in smaller markets: the case of Newfoundland and Labrador.
    Pullman D; Latus A
    Community Genet; 2003; 6(3):178-81. PubMed ID: 15237202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pakistan needs a powerful ethics and integrity body.
    Mukhtar M; Parveen Z
    Nature; 2008 Feb; 451(7181):887. PubMed ID: 18288163
    [No Abstract]   [Full Text] [Related]  

  • 20. New Zealand Bioethics Conference February 2004: emerging biotechnologies: ethics and regulation.
    Evans D
    N Z Bioeth J; 2004 Feb; 5(1):16-21. PubMed ID: 15597488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.